Article
In an upcoming broadcast, Joyce O'Shaughnessy, MD, Shanu Modi, MD, and Anne O’Dea, MD will discuss the approach and goals of the management of certain patients with HER2+ metastatic breast cancer (mBC) and take a deeper look at the burden and unmet needs of the disease. Additionally, they will discuss a second line treatment option for HER2+ mBC.
To obtain expert perspective and learn about the efficacy and safety data of this treatment option, watch the live broadcast on 6/16/2022. To register for the event, visit https://studio.mjhassoc.com/reach/2L-HER2Pos-mBC.
PP-US-ENB-1270 05/22